Atypical uterine leiomyoma: A case report and review of the literature

被引:4
作者
Manxhuka-Kerliu S. [1 ]
Kerliu-Saliu I. [2 ]
Sahatciu-Meka V. [3 ]
Kerliu L. [2 ]
Shahini L. [1 ]
机构
[1] Faculty of Medicine, Institute of Pathology, University of Prishtina, Mother Theresa Street NN, Prishtina
[2] Massachusetts College of Pharmacy and Health Sciences (MCPHS), 179 Longwood Avenue, Boston, 02115, MA
[3] Faculty of Medicine, University of Prishtina, Mother Theresa Street NN, Prishtina
关键词
Atypical uterine leiomyoma; Histology; Immunohistochemistry; Prognostic markers;
D O I
10.1186/s13256-016-0800-3
中图分类号
学科分类号
摘要
Background: Atypical uterine leiomyomas show benign behavior. However, the distinction between leiomyomas and leiomyosarcomas may at times be problematic. We report a rare case of atypical uterine leiomyoma. We try to investigate potential immunohistochemical parameters that could be essential to distinguish cases of malignant smooth muscle tumors and those of uncertain or borderline histology. Case presentation: A 56-year-old white ethnic Albanian woman from Kosovo presented with uterine bleeding because of uterine multiple leiomyomas. A hysterectomy with unilateral adnexectomy was performed. Her hysterectomy specimen contained multiple leiomyomas in submucosal, intramural and subserosal locations. The leiomyomas were well demarcated, firm and white with a whorled cut surface and one had foci of hemorrhage. Histology of most of the leiomyomas showed a whorled (fascicular) pattern of smooth muscle bundles separated by well-vascularized connective tissue. Smooth muscle cells were elongated with eosinophilic or occasional fibrillar cytoplasm and distinct cell membranes. Some of them developed areas of degeneration including hyaline change, with less than five mitotic figures per ten high power fields in most mitotically active areas, and no significant atypia. One leiomyoma was characterized by moderately to severely pleomorphic atypical tumor cells with low mitotic counts and no coagulative tumor cell necrosis. Immunohistochemistry showed strong immunoreactivity for vimentin, smooth muscle actin and desmin, while cyclin-dependent kinase inhibitor 2A (p16), and B-cell lymphoma 2 (bcl-2) showed focal immunoreactivity, estrogen and progesterone were positive, Ki-67 expressed a low proliferation index, whereas p21 and tumor suppressor gene p53 were negative. Conclusions: The combination of evaluation of conventional morphologic criteria with cyclin-dependent kinase inhibitor 2A (p16), p21, progesterone, B-cell lymphoma 2, tumor suppressor gene p53 and Ki-67 expression may be of great value in the assessment of uterine smooth muscle tumors of uncertain or borderline histology. © 2016 Manxhuka-Kerliu et al.
引用
收藏
相关论文
共 16 条
[1]  
Sung C.O., Ahn G., Song S.Y., Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors, Int J Gynecol Pathol, 28, 6, pp. 529-534, (2009)
[2]  
Prayson R.A., Hart W.R., Pathologic considerations of uterine smooth muscle tumors, Obstet Gynecol Clin North Am, 22, 4, pp. 637-657, (1995)
[3]  
Fattaneh A., Tavassoli Peter Devilee: Pathology and Genetics of Tumours of the Breast and Female Genital Organs, (2003)
[4]  
Ip P.P., Cheung A.N., Clement P.B., Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A clinicopathologic analysis of 16 cases, Am J Surg Pathol, 33, 7, pp. 992-1005, (2009)
[5]  
Bodner-Adler B., Bodner K., Czerwenka K., Expression of p16 protein in patients with uterine smooth muscle tumors: An immunohistochemical analysis, Gynecol Oncol, 96, 1, pp. 62-66, (2005)
[6]  
O'Neill C.J., McBride H.A., Connolly L.E., Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential, Histopathology, 50, 7, pp. 851-858, (2007)
[7]  
Atkins K.A., Arronte N., Darus C.J., The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors, Am J Surg Pathol, 32, 1, pp. 98-102, (2008)
[8]  
Ly A., Mills A.M., McKenney J.K., Atypical leiomyomas of the uterus: A clinicopathologic study of 51 cases, Am J Surg Pathol, 37, 5, pp. 643-649, (2013)
[9]  
Mills A.M., Ly A., Balzer B.L., Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: Immunohistochemical study of 68 cases with clinical follow-up, Am J Surg Pathol, 37, 5, pp. 634-642, (2013)
[10]  
Unver N.U., Acikalin M.F., Oner U., Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors, Arch Gynecol Obstet, 284, 2, pp. 483-490, (2011)